Seeking Alpha

Shai Novik  

Mr. Novik founded PROLOR Biotech, Inc., a biopharmaceutical company developing long-acting therapeutic proteins, in 2005, and served as its President through its acquisition by OPKO Health (NYSE: OPK) in 2013, a $560 million transaction. Mr. Novik is a co-founder of GlassesOff, and previously served as Chief Operating Officer and Head of Strategic Planning of THCG, a technology and life sciences investment company. THCG was a portfolio company of Greenwich Street Partners, one of the largest U.S. private equity funds. THCG's own portfolio included several life sciences and medical devices companies. Mr. Novik earned his M.B.A. degree, with Distinction, from Cornell University.

Currently, you have no snapshot. Click edit to add details such as trading frequency and investing interests.

Currently, you have no company profile. Click edit to add a company profile.
Currently, you have no blog details. Click edit to add blog details.
Currently, you have no book details. Click edit to add book details.